Request for Proposal
Please take a few moments to share some information with us and we will be in touch shortly.
Submit NowNeuro-Psychiatry
Our capabilities for quality and timely execution of Neuro-Psychiatry clinical trials
- Medical adviser/KOL with >3 decades of experience in the Psychiatry area
- Access to sites with large databases of psychiatry patients and good infrastructure (Rehabilitation and De-addiction centers) to handle studies requiring long term confinement
- A pool of qualified, trained, and experienced investigators having expertise in administering complex Neuro-Psychiatry assessments which is the most critical aspect of Neuro-Psychiatry trials having subjective primary endpoints
- Direct access to dedicated PSYCH unit in California to perform psychiatry studies
- Quick turnaround time for study document finalization/translations/EC submission/regulatory submission
Experience
- Schizophrenia
- Bipolar I disorder
- Parkinson’s disease
- Seizures
- Myasthenia gravis
- Schizoaffective disorder
8 studies on Long-acting injections across 60+ sites
Four 505(b)(2) programs out of which one study involves Neonates
Provided support to applicants in drafting strategy and protocol for obtaining pediatric exclusivity
Sample size ranging from 24 to 320 patients
Patient dropout rate of <10%
Long-term patient involvement ranging from 6-12 months
Scientific Advisory Board
Dr Jonathan McKinnon
Dr Jonathan McKinnonFounder, The Las Vegas Clinic
Dr. McKinnon earned his Doctor of Medicine degree from the Ohio State University. He then completed his residency in neurology, and fellowship in clinical neurophysiology from the Mayo Clinic, Arizona. He earned another fellowship in clinical neuromuscular medicine from the University of California, Irvine.
Dr. McKinnon is the founder of the Las Vegas Clinic, a center of excellence for diagnosis and management of neurological disorders. His practice focuses on evaluation and management of disorders involving the peripheral nerve and muscle and brings a comprehensive approach in neurology and the neuromuscular space. Dr. McKinnon is a board-certified neurologist with a specialty board certification in neuromuscular medicine.
With Dr. McKinnon as our KOL in neurology, we are poised to support our global biopharmaceutical companies in their neurology trials in the USA. We aim to build flexible, agile and efficient CRO operation, tailored to suit your clinical development needs.
Dr Parth Goyal
Dr Parth GoyalConsultant Psychiatrist, Parth Hospital and CIMS Hospital
Dr Parth Goyal has done his M.B.B.S. (Bachelor of Medicine, Bachelor of Surgery) from Bharati Vidhyapeeth Deemed University Medical College, India (2014) and completed M.D. (Psychiatry) in 2017, from Sumandeep Vidyapeeth University, Vadodara. He has completed 3 years of residency training in Psychiatry, at the Department of Psychiatry, Smt B.K. Shah Medical College and Research Centre, Sumandeep Vidyapeeth.
He is currently working as a Consultant Psychiatrist at Parth Hospital and CIMS Hospital since 2017. He has been a Research Associate at Yale School of Medicine, Department of Psychiatry, U.S.A. (2014) where he worked on Repetitive Transcranial Magnetic Stimulation, and its role in the reduction of Auditory Hallucination in treatment-resistant schizophrenia under the guidance of Dr Ralph Hoffman. He has also done a clinical rotation for 1 month, in in-patient services at Yale Psychiatric Hospital, Yale University, U.S.A., under the supervision of Dr Robert Ostroff. He has achieved a clinical attachment with the National Health Scheme (United Kingdom) under the guidance of Dr A. N. Chowdhary. He has also been selected as an associate student member to the International Academy of Behavioral Medicine, Counseling, Psychotherapy and Chemical Dependence, Texas, as an associate student member.
His research experience includes thesis work, poster and paper presentation at various national and international level. His thesis work was “Evaluating the effectiveness of the transcranial direct current stimulation (tDCS) as an augmenting agent in patients with anti-psychotic resistant auditory hallucination in schizophrenia (A Study Of 55 Subjects)”, under the guidance of Dr Lakhan Kataria at Sumandeep Vidyapeeth University, Vadodara.
His areas of interest include neuro-stimulation and addiction medicine. Apart from professional work, he is also involved in various community work including an awareness project for promoting prevention against Oral Cancer, which included a Skit presentation in Rural Slums and house-to- house awareness program. He has undertaken a research project on “Training and Assessment of General Practitioners about Malaria Awareness” and organized a CME for the Training and Update of General Practitioners concerning malaria awareness.
His career objective is to provide comprehensive care to patients suffering from mental illnesses, understand mental illness from a biological standpoint and to provide individualized treatment to each patient, by accommodating the cultural, social and biological factors.